학술논문
Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence
Document Type
article
Author
Omid Hamid; Brendan Curti; Craig L Slingluff; Mohammed Milhem; Jose Lutzky; Suthee Rapisuwon; Brian Gastman; Takami Sato; Marcus O Butler; Robert Andtbacka; Eddy Hsueh; Robert Weber; John Glaspy; Sekwon Jang; Sajeve Thomas; Karl D Lewis; Leonel Hernandez-Aya; John Hyngstrom; Adam Berger; Edward Levine; Montaser F Shaheen; Vinay Gupta; Svetomir N Markovic; Tawnya Bowles; Joel Claveau; Prejesh Philips; Shernan G Holtan; William Schmidt; Juan Paramo; Arvinda Padmanabhan; Daniel Milton; Andrew Pecora; Suprith Badarinath; John Keech; Sujith Kalmadi; Pallavi Kumar; Anna Bar; J Thaddeus Beck; Jeffrey B Travers; Catalin Mihalcioiu; Peter Beitsch; Edward C McCarron; Deepti Behl; Brent Blumenstein; Joanna J Peterkin
Source
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
Subject
Language
English
ISSN
2051-1426